Coherent and SiOnyx Collaborate to Gain New Opportunities in the Solar Industry

Coherent, Inc. (Santa Clara, CA)  (Nasdaq: COHR) and SiOnyx, Inc. (Beverly, MA) announced they have entered into a joint development agreement for solar cell capital equipment (tools) manufacturing utilizing SiOnyx’s Black Silicon processing that is based upon the interaction of ultrafast laser light and silicon in a controlled environment. Black Silicon offers the potential of a number of advantages over currently deployed technologies, including reduction of costs, an increase of conversion efficiencies, and improvements in manufacturing yields.

Stephen Saylor, President and Chief Executive Officer of SiOnyx commented,“Partnering with Coherent gives SiOnyx access to the industry’s most advanced ultrafast laser technology and allows us to continue the rapid pace of advancement of the Black Silicon platform. With this collaboration, we look forward to demonstrating the scalability of our process beyond the initial applications of photodetection and imaging and exploit the compelling benefits of Black Silicon’s enhanced quantum efficiency in the solar industry.”

“We are excited that this agreement brings together SiOnyx‘s unique process expertise with Coherent ultrafast laser technology to increase the pace of development in this exciting area,” said John Ambroseo, Coherent’s President and Chief Executive Officer. “Together with our rapidly growing solar tools business, it will position both companies to capture new opportunities in the photovoltaic industry as it continues to expand towards grid parity.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.